← Leaderboards
Diana M Escolar
Children'S Research Institute
$932,040
Attributed
$932,040
Total exposure
21
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $168.5K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$932,040 · 21
By mechanism
K23$621,959 · 1
M01$310,081 · 20
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Adeline Lucie Vanderver$19,932,242
- Laurie S Conklin$1,527,676
- Mark L Batshaw$21,890,139
- Monika Kumari Goyal$10,511,739
- Karun V Sharma$2,162,173
Others in their field
Top investigators on “Muscular Dystrophy”
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$53,688,339
- Stephen J. Tapscott · Fred Hutchinson Cancer Center$24,320,230
- Elizabeth M McNally · University Of Chicago$24,290,327
- Eric P Hoffman · Reveragen Biopharma, Inc.$24,157,975
- Charles A Thornton · Virginia Commonwealth University$22,039,420
- Krista H Vandenborne · University Of Pennsylvania$21,082,899
Research focus
Muscular DystrophyHuman Therapy EvaluationPatient Oriented ResearchHuman SubjectMuscle StrengthGrantUnited States National Institutes Of HealthInstitutionResourcesSourceFundingDrug Screening /EvaluationMuscleComputer Retrieval Of Information On Scientific Projects DatabaseExerciseResearch PersonnelMaleClinical TrialsUbiquinoneCareerMitochondriaLongitudinal Human StudyCreatineMuscle Disorder Chemotherapy
Grant awards (25)
CNMC0705: A DOUBLE-BLINDED RANDOMIZED PLACEBO CONTROLLED STUDY OF DAILY$58,186
M01 · FY2008 · RR · contact PI
3147K2-101-WW: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTIPLE ASCENDY$21,220
M01 · FY2008 · RR · contact PI
CNMC0601: A RANDOMIZED STUDY OF DAILY VS HIGH-DOSE WEEKLY PREDNISONE IN DUCHEN$21,220
M01 · FY2008 · RR · contact PI
CNMC0705: A DOUBLE-BLINDED RANDOMIZED PLACEBO CONTROLLED STUDY OF DAILY$27,015
M01 · FY2007 · RR · contact PI
3147K2-101-WW: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTIPLE ASCENDY$9,852
M01 · FY2007 · RR · contact PI
CNMC0601: A RANDOMIZED STUDY OF DAILY VS HIGH-DOSE WEEKLY PREDNISONE IN DUCHEN$9,852
M01 · FY2007 · RR · contact PI
3147K2-101-WW: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTIPLE ASCENDY$60,920
M01 · FY2006 · RR · contact PI
CNMC0601: A RANDOMIZED STUDY OF DAILY VS HIGH-DOSE WEEKLY PREDNISONE IN DUCHEN$13,939
M01 · FY2006 · RR · contact PI
CNMC0705: A DOUBLE-BLINDED RANDOMIZED PLACEBO CONTROLLED STUDY OF DAILY$10,842
M01 · FY2006 · RR · contact PI
CNMC0302: AN OPEN-LABEL PILOT STUDY OF PENTOXYFILLINE IN STEROID NAIVE DUCHENNE$3,098
M01 · FY2006 · RR · contact PI
CNMC0301: AN OPEN-LABEL PILOT STUDY OF COENZYME Q10$2,582
M01 · FY2006 · RR · contact PI
Mentored Patient Oriented Research Career Development$124,848
K23 · FY2005 · RR
RANDOMIZED STUDY OF DAILY VS HIGH DOSE WEEKLY PREDNISONE THERAPY IN DMD$12,457
M01 · FY2005 · RR
OPEN-LABEL PILOT STUDY OF PENTOXIFYLLINE IN STEROID-NAIVE DMD$9,707
M01 · FY2005 · RR
CNMC0301: OPEN-LABEL STUDY OF COENZYME Q10 IN STEROID-TREATED DMD$9,707
M01 · FY2005 · RR
GENE EXPRESSION PROFILE IN INDIVIDUALS &FAMILIES W/ EMERY-DREIFUSS MD$5,950
M01 · FY2005 · RR
OPEN-LABEL PILOT STUDY OF OXATOMIDE IN STEROID-NAIVE DUCHENNE MUSCULAR DYSTROPHY$5,824
M01 · FY2005 · RR
Mentored Patient Oriented Research Career Development$124,848
K23 · FY2004 · RR
CNMC0301: An Open-Label Pilot Study of Coenzyme Q10$14,732
M01 · FY2004 · RR
KUL0401: An open-label pilot study of oxatomide in steriod-naive Duchenne Mus$10,173
M01 · FY2004 · RR
CNMC0601: A randomized study of daily vs. high-dose weekly prednisone in Duchen$2,455
M01 · FY2004 · RR
CNMC0302: An open-label pilot study of pentoxyfilline in steroid naive Duchenne$350
M01 · FY2004 · RR
Mentored Patient Oriented Research Career Development$124,848
K23 · FY2003 · RR
Mentored Patient Oriented Research Career Development$124,301
K23 · FY2002 · RR
Mentored Patient Oriented Research Career Development$123,114
K23 · FY2001 · RR